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Objective: Obesity has been associated with markers of increased systemic inflammation in both human
and animal studies. Increased inflammation is linked to metabolic and cardiovascular disease. The objec-
tive of this study was to evaluate the association between percentile body fat and inflammation in a
nationally representative sample of US children.
Methods: 6,950 children 8-18 years of age between 1999 and 2004 were studied. Measurement of body
fat percentage was measured by dual-energy X-ray absorptiometry scan and converted to an age- and
sex-adjusted percentile. The main outcome measures were abnormal c-reactive protein (CRP > 1.0 mg/
dl) and absolute neutrophil count (ANC > 6,600).
Results: Children with higher levels of body fat (70th percentile) had a higher odds of having elevated CRP
(OR 2.88-10.69) and elevated ANC (OR 2.14-3.24) compared with children with body fat <70th percentile.
Conclusions: The link between inflammation and body fat in children warrants further longitudinal
research to understand the temporal relationship between overweight/obesity and inflammation in the
pediatric obese population and its implications for chronic disease risk.
Obesity (2014) 22, 1332-1336. doi:10.1002/oby.20710
Introduction
Studies in both animals and humans suggest that visceral adipose
tissue is a major source of pro-inflammatory signals, including cyto-
kine production and macrophage activation (1,2). This obesity-
induced inflammation contributes to the pathogenesis of cardiovas-
cular disease, hypertriglyceridemia, and insulin resistance (3-5), and
may additionally be linked to increased risks of cancer (6), autoim-
mune diseases, and sepsis (7).
Epidemiologic studies in adults and children (8) have shown that
elevated body mass index (BMI) is associated with elevated sys-
temic markers of inflammation including C-reactive protein (CRP)
and peripheral leukocyte counts (9). There have been few clinical
studies that have investigated pediatric obesity and inflammation
using CRP and other inflammatory cytokines such as TNFa and
IL6 (10). However, these studies have had a relatively small sam-
ple size (11-13) or have used BMI as a surrogate marker of obe-
sity status (9). BMI correlates fairly well with body fat in adult
populations; nonetheless it is an imperfect measure of adiposity
especially in the pediatric population (14,15). Given that BMI
does not directly correlate to body fat (16), additional studies are
needed to directly evaluate the relationship between body fat and
inflammation in children in the context of a national epidemic of
childhood obesity.
Our objective was to assess whether excess body fat, as measured
by a more robust standard method for measuring body fat dual
energy X-ray absorptiometry (DEXA), is associated with elevations
in clinical markers of inflammation, including abnormal levels of
CRP and absolute neutrophil count, in a nationally representative
US pediatric population (N 5 6,950).
Methods
We used data from the National Health and Nutrition Examination
Survey (NHANES) 1999-2004, a cross-sectional, nationally repre-
sentative examination study of the US civilian noninstitutionalized
population (17) which oversamples individuals 12-19 years, as well
as minority populations. In the survey, a subset of individuals had
inflammatory markers performed, including high sensitivity CRP
levels (measured by latex-enhanced nephelometry) (18) and absolute
neutrophil counts (19) (see references for assay details).
NHANES captured measures of body fat using whole body DEXA
scans in a subset of individuals 8 years and older using a Hologic
QDR 4500 fan-beam densitometer (Hologic, Bedford, MA). Scans
were conducted in the fast mode by trained radiology technologists
and were analyzed using Hologic DOS software version 8.26:a3)
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(17). Detailed documentation of the procedures for the DEXA scans
is available online (17).
Our main outcome variable of interest was an elevated CRP, which
was defined as a level > 1.0 mg/dl, which is consistent with defini-
tions used for assessing inflammation in the pediatric population (9).
This is based on previous studies that have shown an association
between a CRP > 1.0 mg/dl and increased cardiovascular and meta-
bolic disease risk (20) and has previously been used in pediatric
studies (21). We also assessed a secondary marker of inflammation,
defined as an absolute neutrophil count (ANC) > 6,600, a threshold
that has been used by other studies for defining the presence of
inflammation and is the 95th percentile for this population (9).
Our independent variable was total percentage body fat, which was
converted to an age- and sex-adjusted percentile for percentage
body fat recently published by the CDC (22). The definition of
“normal” percentage body fat adjusted for age and sex is not clear;
therefore, similar to previous studies, (14) we defined thresholds at
the 70th, the 85th, and the 90th percentile of percentage body fat,
as these thresholds captured similar proportions of children in the
overweight (31.9% have a BMI  85th percentile), obese (16.3%
have a BMI  95th percentile), and severely obese (11.3% have a
BMI  97th percentile) categories, respectively (23). We used
“normal” percentage body fat (5-69th percentile) as our referent
group for our analyses. We eliminated those under 5th percentile
to eliminate underweight children who may be categorized as fail-
ing to thrive and are likely to have underlying disease or illness
and hence CRP or ANC that may be falsely elevated.
For the CRP analysis, of 6,950 children aged 8-18 years of age with
DEXA data, we excluded 646 children with missing CRP data, 320
children with an incomplete scan, one child with a CRP >10, and
356 children were excluded for a percentage body fat less than 5th
percentile, leaving a sample size of 5,627.
Compared with the children excluded from our study for missing
CRP, children in our sample were older (13.1 years vs. 12.2 years,
P 5 0.001), but there were no differences by sex, body fat, BMI, or
race.
For the ANC analysis, of 6,950 children 8-18 years of age with
DEXA data, we excluded 579 children with a missing ANC data, 327
children with an incomplete scan, 64 children with a CRP > 10 and
356 children with a percentage body fat less that 5th percentile, leav-
ing a sample of 5,624 children. Compared with the children excluded
from our study for missing ANC, children in our sample were older,
with a mean age of 13.1 vs 12.1 years (p 5 0.001). However, there
were no significant differences by sex, body fat, BMI, or race.
Statistical Analysis
We performed bivariate analyses using simple logistic regression to
examine the association between abnormal CRP or ANC across the
different categories of body fat percentiles. We then performed multi-
variable logistic regression models predicting these outcomes, which
adjusted for age, sex, and race, and used the 5-69th percentile group
as the reference category. We tested for race by body fat percentiles
(White, Black, Mexican-American), age by body fat percentile and,
sex by body fat percentile interactions. In additional sensitivity analy-
ses, we conducted logistic regression using body fat percentile as a
continuous variable predicting abnormal CRP or ANC, and we per-
formed linear regression using body fat percentile as a continuous
variable predicting CRP as a continuous variable. Finally, we also
conducted additional analyses using total body fat mass and its associ-
ation with CRP and ANC as continuous or dichotomous outcomes,
adjusting for total mass, age, race, and gender.
The NHANES surveys use a complex sample survey design and
weighting methodology (17). We used STATA 11.0 statistical
TABLE 1 Descriptive characteristics of total population by race
Overall population White Black Hispanic Other
N 5,627 1,543 (62.4%) 1,678 (13.4%) 2,199 (18.4%) 207 (5.8%)
Male 3,331 (59.2%) 887(58.7%) 989 (58.8%) 1,337 (59.8%) 118 (62.7%)
Age (mean) 13.1 13.2 13.0 13.0 13.3
BMI
Underweight (<5th percentile) 130 (2.7%) 43 (2.8%) 28 (1.7%) 52 (2.6%) 7 (4.1%)
Normal weight (5-84th percentile) 3,260 (60.7%) 975 (62.8%) 904 (53.5%) 1,251 (56.6%) 130 (67.3%)
Overweight 1,008 (17.6%) 257 (17.1%) 318 (18.9%) 405 (19.6%) 28 (15.0%)
Obese 1,207 (19.0%) 263 (17.3%) 422 (25.9%) 481 (21.2%) 41 (13.6%)
Body Fat Percentile
<5th - - - - -
5th-69th 3,819 (69.6%) 1,091 (70.6%) 1,216 (72.0%) 1,362 (62.1%) 150 (77.2%)
70th- 84th 874 (15.1%) 223 (14.5%) 206 (12.7%) 417 (19.9%) 28 (11.5%)
85th-89th 341 (5.8%) 87 (5.8%) 93 (5.4%) 150 (6.5%) 11 (4.8%)
 90th 593 (9.5%) 142 (9.1%) 163 (10.0%) 270 (11.5%) 18 (6.6%)
Abnormal CRP 192 (2.8%) 40 (2.7%) 65 (3.8%) 86 (3.1%) 1 (0.1%)
Abnormal ANC 389 (7.5%) 127 (8.1%) 43 (2.7%) 207 (9.6%) 12 (6.0%)
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software, which incorporates appropriate sampling weights to adjust
for the complex sample design. NHANES provides the DEXA data
as multiply imputed datasets because of nonrandom missing data.
Therefore, we performed analyses on each of the multiple imputa-
tion datasets and combined results using STATA.
This study was considered exempt by the University of Michigan
Institutional Review Board.
Results
Table 1 shows the overall population characteristics as well as the
characteristics based on ethnicity. There were no differences by age
or gender, but there were differences by race, with a greater percent-
age of elevated CRP for Mexican and non-Hispanic Black children
(P 5 0.0006). Overall 2.8% (n 5 192) of children had an abnormal
CRP and 7.5% (n 5 389) of children had an elevated ANC. As
shown in Table 1 we created categories of body fat percentiles to
match population distributions according to weight status. Based on
BMI, 17.6% of children were overweight and 19% were obese.
Accordingly, 15.1% of children were between 70th and 84th percen-
tile body fat (to match the overweight category), and 5.8% and
9.5% were in the 85-89th and the 90th percentile categories (to
overall match the obese category).
Table 2 shows the results of the multivariable logistic regression mod-
els. With increased body fat, there was an increasing odds ratio of hav-
ing abnormal CRP. For example, compared with children with body
fat in the 5-69th percentile, those with body fat 70-89 percentile had
approximately three times the odds of abnormal CRP, and children
with body fat 90th percentile had approximately 10 times the odds
of abnormal CRP. We found similar results for abnormal ANC with
those in the 70-89 percentile had two times the odds of having ele-
vated ANC and those with 90th percentile had three times the odds
of having an elevated ANC. We did not find any statistically signifi-
cant interactions for age, sex, or race with body fat percentiles.
In additional models, for each one percentile increase in body fat,
there was a 13% higher odds of having abnormal CRP (P < 0.001)
and for each 1% increase in body fat percentile there was a 7% odds
of having elevated ANC (P < 0.001). In linear regression analyses,
each 1 percentile increase in body fat was associated with a 0.01
increase in CRP (P < 0.001) and each 1 percentile increase in body
fat was associated with a 0.05 increase in ANC (P < 0.001).
We found a consistent association of body fat with inflammatory
markers, even when we used raw body fat mass, as the independent
variable (see Tables 3 and 4).
Discussion
To our knowledge this is the first study to report a link between
body fat percentile, a standard measure of adiposity, and inflamma-
tion, in a large representative population-based sample of US chil-
dren. We found that a higher level of body fat was associated with
higher odds of having abnormal CRP and ANC, which highlights
the fact that the association between adiposity and inflammation
occurs during childhood as well as in adulthood.
Our study provides evidence of a robust link between obesity and
inflammation in children (9,11), which builds upon prior pediatric
studies that have used proxy measures of body fat. Smaller pediatric
studies have found a significant association between adiposity and
CRP in even nonobese children as defined by BMI. McVean et al.
investigated 75 children with BMI <95th percentile and found that
percent body fat was a predictor of CRP (24).
Other pediatric studies have used the NHANES data to evaluate the
link between adiposity and inflammation using proxy measures for
TABLE 2 Unadjusted and Adjusted analyses showing the odds
ratio (OR) for elevated inflammatory parameters (C-Reactive
Protein or Absolute Neutrophil Count) when compared to
referent group of 5-69 percentile body fat for age and
gender
Abnormal C-reactive Protein
(>1.0 mg/dl) OR (95% CI)
Categories of
percentile body fat Unadjusted
Adjusted for age,
race, gender
5-69% Referent Referent
70-84% 2.88** (1.35-6.12) 2.85** (1.32-6.26)
85-89% 3.67*** (1.69-7.96) 3.61*** (1.66-7.86)
90% 10.69**** (5.69-20.09) 10.52**** (5.66-20.25)
Absolute Neutrophil
Count (>6,600) OR (95% CI)
Categories of
percentile body fat Unadjusted
Adjusted for age,
race, gender
5-69% Referent Referent
70-84% 2.14**** (1.44-3.16) 2.14*** (1.42-3.21)
85-89% 2.03* (1.11-3.73) 2.06* (1.07-3.95)
90% 3.24**** (2.17-4.85) 3.38**** (2.22-5.08)
*P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001
TABLE 3 Linear regression of CRP or ANC as outcome with total fat as predictor adjusted for total body mass, sex, race/
ethnicity, and age
CRP ANC
Coefficient SE P-value Coefficient SE P-value
Total Body Fat Mass 0.000020 0.000002 <0.001 0.00007 0.00001 <0.001
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body fat. Skinner et al. found an increased hazard ratio for elevated
CRP in very obese children (>99th percentile by BMI) starting at 3-
5 years of age (HR 2.29; P < 0.01) up to children 15-17 years of
age (HR 4.73; P < 0.01). Similarly, they also found an increased
HR for elevated ANC of 2.0 in very obese children starting as
young as 6-8 years of age (9). More recently, Going et al. assessed
NHANES data for the relationship between skin fold measures of
body fat and elevated CRP (25). They reported that those with
higher percent body fat by skin fold (>20-30% in boys and > 25-
35% in girls) had 6-10 folds higher odds of elevated CRP. These
data are consistent with our results but are proxy measures for the
percent body fat assessments used in this study.
Our findings are consistent with adult studies that have used popula-
tion based data. For example, using NHANES data, Visser et al.
found that obese males were 2.13 times more likely and obese
females were 6.21 times more likely compared to normal-weight
counterparts to have an increased CRP/cardiovascular disease risk
with adiposity estimates by BMI with (8). Menke et al. used a vari-
ety of adiposity measures (waist circumference, BMI, % body fat,
and skin fold thickness) and also found that adiposity was linked
with elevated CRP in males and females (8,26).
Strengths of our study include the representative nature of the
NHANES database, the racial/ethnic diversity of the population, and
the relatively large number of children with DEXA scans performed.
We used measures of body fat from DEXA scans, which represent a
current standardized measure for body fat, and we used recently
published percentiles for percentage body fat which account for age
and gender differences (22). Finally, we found an association
between percentile body fat and inflammation using two different
inflammatory markers, although we acknowledge that further studies
are necessary to determine the clinical relevance of these markers.
We also acknowledge limitations of this study. Because DEXA was
only performed in older children, we were unable to examine the
association among younger children (27). We used a cross-sectional
study design and therefore cannot prove causality. We acknowledge
that multiple measurements are needed to categorize an individual
as having failure to thrive, so we may have missed children in this
category by relying on just one measurement. Finally, we acknowl-
edge that there is not a clear consensus what constitutes a “normal”
percent body fat in children, but we did find similar results in our
analyses which evaluated body fat percentile as a continuous vari-
able and which evaluated raw total body fat as well.
Obesity is a significant problem starting in young children, yet we do
not clearly understand the long-term sequelae of obese children and
this early inflammation. In adult studies, obesity and its correlated
inflammation place individuals at risk for early metabolic and cardio-
vascular disease. Early inflammatory activation may be associated
with other disease processes such as cancer (28), autoimmune condi-
tions (29), and asthma (30). Our findings emphasize that young chil-
dren with increased body fat for age and gender also have increased
systemic inflammation and emphasizes the need to further investigate
the relationship of inflammation and body fat accumulation in longi-
tudinal studies. Such studies can clarify the temporal relationship
between inflammation and adiposity along with the time course for
development of subsequent metabolic and cardiovascular disease. O
VC 2014 The Obesity Society
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